Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
about
JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indicationsCD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaChildhood acute lymphoblastic leukemia: Integrating genomics into therapyPrognostification of ALL by CytogeneticsLNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitorsIntegration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray studyInherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison.Childhood B-acute lymphoblastic leukemia: a genetic update.The molecular regulation of Janus kinase (JAK) activationOutcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells.Improving access to novel agents for childhood leukemia.Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy.Improving the outcome for children with cancer: Development of targeted new agents.Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaAnalysis of Patterns of Gene Expression Variation within and between Ethnic Populations in Pediatric B-ALLIndependent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.Genomic characterization of childhood acute lymphoblastic leukemia.The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia.High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.Predicting relapse risk in childhood acute lymphoblastic leukaemia.Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies.New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL.Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia.Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.CD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia.Ph-like acute lymphoblastic leukemia.Novel therapy for childhood acute lymphoblastic leukemia.Rapid Capture Next-Generation Sequencing in Clinical Diagnostics of Kinase Pathway Aberrations in B-Cell Precursor ALL.BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures.Philadelphia chromosome-like acute lymphoblastic leukemia.
P2860
Q26782539-48EE20D9-31C2-42C0-9795-73CF15E94E35Q26783433-0BFE1E17-930A-41DF-9B8B-2D9334788C41Q27025242-AAADB29F-5912-4CB1-9CCA-7366029DB5D8Q28080463-C8F68B15-B9F0-47D7-9699-863148EB01DAQ28087446-D2032495-CE5A-4CA2-8A13-E5BF492D2AC1Q28274115-2FBAF41E-D414-487B-A8D2-8ECA238BE837Q30842603-0E0CADB1-9C69-4DA9-BE4E-7210ED93C71DQ33688248-DDD16CBD-8B32-45A3-BA7E-F4345477D133Q33711119-44878CF1-57ED-4308-B0BD-039B345DE26CQ33729728-3AD8122F-DF8F-4C8A-95C7-6A4DB5B4F3E3Q33777616-2BFAA6A7-184B-4187-9C23-7C0C2F89122BQ33956113-F9F8547E-51E5-42E9-AF31-BE0BE9CA6E15Q34172033-119D3840-5245-4AE3-97E6-9A3F2B608CEAQ34314927-11BCA527-2ED2-4EA8-B83C-C4CF118B0811Q35273390-76350E53-EBC1-48DD-9512-A9AB13A33185Q35688742-4E605F88-D980-481C-A4C0-CB4380712425Q35894536-C513CACF-9080-49B0-BB02-05D401302292Q35904943-957EDE24-5451-4601-8AF2-92E60D830140Q35987564-5BDCACE2-33E0-41B7-B48E-03F828944E44Q36134458-5EB9BB92-CC21-42B1-B71E-30E2AEDB00DAQ36238795-94947F96-D301-4A97-8954-041407A30E89Q36717196-F99F9891-BE67-44E8-9780-5EBCDA38FAA8Q37146303-5095702C-5188-4EA6-B7C3-B16CACF16E6BQ37226741-AB6E8434-30A5-47F4-A1A2-DA904F91EDB0Q37359118-0C87876D-88DE-42E7-98F7-141D4A0A1CF7Q37629537-FFC54B2B-A366-48A9-B596-1317D66B532BQ37739018-2D2E8197-9FE9-40E7-A23E-5B172A545FE0Q38117685-6D1FF5DB-48B9-4E99-B542-903A45B27F79Q38218128-7A321727-E7E8-49A7-83E9-D000E44AB9A4Q38220573-629B7768-2E37-4AE1-AE1F-2E0243E8469EQ38289046-CE4563F6-5825-4AF1-9151-18A75926F5DBQ38289596-50977AC3-1C21-4424-9ADB-5F2D96413487Q38381463-650865E9-FEE5-4B3A-800B-7315AE17C93EQ38460308-4226E621-D6F3-4299-B9B7-9D925F0AC532Q38776573-44269351-8DB2-4820-8549-86C7EA64E098Q39027852-3F330557-5FFB-4563-BC37-8587838D555AQ39368957-C2239C7E-62CB-49D2-ABDC-E37C255F006BQ40836915-4EE9F167-BEE7-49E9-B614-97AE06E0B653Q42943355-7ECF9277-1D24-4019-8D4F-75599E6B7A21Q43431904-3C66ACC4-D3E9-4A3B-B433-CD4013D47F2F
P2860
Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tyrosine kinome sequencing of ...... Oncology Group TARGET Project
@ast
Tyrosine kinome sequencing of ...... Oncology Group TARGET Project
@en
type
label
Tyrosine kinome sequencing of ...... Oncology Group TARGET Project
@ast
Tyrosine kinome sequencing of ...... Oncology Group TARGET Project
@en
prefLabel
Tyrosine kinome sequencing of ...... Oncology Group TARGET Project
@ast
Tyrosine kinome sequencing of ...... Oncology Group TARGET Project
@en
P2093
P2860
P50
P1433
P1476
Tyrosine kinome sequencing of ...... Oncology Group TARGET Project
@en
P2093
Brent Wood
Cheryl L Willman
Daniela S Gerhard
Debbie Payne-Turner
Elizabeth Raetz
Eric Larsen
Huining Kang
I-Ming Chen
James R Downing
P2860
P304
P356
10.1182/BLOOD-2012-04-422691
P407
P577
2012-12-04T00:00:00Z